Skip to Content Facebook Feature Image

Cardinals' Marvin Harrison Jr. shows mercurial side with TD, bobbled pass against Seahawks

Sport

Cardinals' Marvin Harrison Jr. shows mercurial side with TD, bobbled pass against Seahawks
Sport

Sport

Cardinals' Marvin Harrison Jr. shows mercurial side with TD, bobbled pass against Seahawks

2025-09-26 12:51 Last Updated At:13:11

GLENDALE, Ariz. (AP) — Marvin Harrison Jr. soared above a defensive back, snagged the ball at the high point and pulled it down for a key touchdown in Arizona's comeback attempt.

The Cardinals' second-year receiver didn't celebrate, opting instead to kneel with an arm over the front of his helmet before jogging off the field.

After the first half he had, Harrison seemed more relieved than excited about pulling down a highlight-reel touchdown.

Harrison caught a touchdown pass and had a pair of key catches on Arizona's final drive, but also bobbled a pass that led to a first-half interception in the Cardinals' 23-20 loss to the Seattle Seahawks on Thursday night.

“I'm not worried about Marv at all,” Cardinals coach Jonathan Gannon said. “He's going to be just fine. He's resilient, just as this whole crew is.”

The Cardinals (2-2) will need to be after losing consecutive games on the final play of regulation for the first time since moving to Arizona in 1988, this one from 52 yards by Seattle's Jason Myers as time expired.

Harrison's night mirrored Arizona's.

The Cardinals labored early while falling into a 17-3 by early third quarter. Harrison had a first half to forget, cutting off a route on Kyler Murray's first interception, bobbling another pass right into the hands of Seattle's Earnest Jones IV for a second pick.

The online ire toward Harrison rose after the second gaffe and Arizona's fans let out a sarcastic cheer when the son of Hall of Famer Marvin Harrison hauled in a toe-tapping catch along the sideline in the third quarter.

But as the Cardinals mounted a comeback, Harrison was right in the middle of it.

The 23-year-old showed off his athleticism on the touchdown, rising over cornerback Seattle Devon Witherspoon to pull down the catch along the sideline. Harrison caught two passes on Arizona's final drive, including an 18-yard, back-shoulder snag that set up Emari Demercardo's tying 7-yard run with 28 seconds left.

“Marvin is hard on himself, expects so much of himself,” Murray said. “He drops the ball and I'm sure that's lingering in his mind, but I love the way he fought back.”

The Cardinals used the fourth overall pick of the 2024 draft to select Harrison out of Ohio State, hoping he would become their No. 1 receiver.

Harrison showed flashes of potentially being that guy during his rookie season, catching 62 passes for 885 yards and eight touchdowns. He bulked up during the offseason and so did the expectations.

Harrison had a touchdown catch in Arizona's opening win at New Orleans, but was limited to two catches for 27 yards the next week against Carolina. He had three catches for 44 yards last week at San Francisco and dropped two passes, including one that would have been a touchdown.

Harrison was dejected following the 16-15 loss and again in the first half against the Seahawks, leading to a pep talk from Murray.

“I need him. He needs me, I need him," Murray said. "He’s not coming out of the game and I don’t want him to. It's just a conversation to keep his confidence up.”

The Cardinals need a confident Harrison if they're going to bounce back from consecutive heartbreaking losses. The finish against the Seahawks may be just what he needed.

AP NFL: https://apnews.com/NFL

Seattle Seahawks linebacker Ernest Jones IV (13) intercepts a pass intended for Arizona Cardinals wide receiver Marvin Harrison Jr. (18) during the first half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Rick Scuteri)

Seattle Seahawks linebacker Ernest Jones IV (13) intercepts a pass intended for Arizona Cardinals wide receiver Marvin Harrison Jr. (18) during the first half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Rick Scuteri)

Arizona Cardinals wide receiver Marvin Harrison Jr., right, catches a touchdown pass as Seattle Seahawks cornerback Devon Witherspoon and safety Coby Bryant (8) defend during the second half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Ross D. Franklin)

Arizona Cardinals wide receiver Marvin Harrison Jr., right, catches a touchdown pass as Seattle Seahawks cornerback Devon Witherspoon and safety Coby Bryant (8) defend during the second half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Ross D. Franklin)

Arizona Cardinals wide receiver Marvin Harrison Jr., right, catches a touchdown pass as Seattle Seahawks cornerback Devon Witherspoon defends during the second half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Rick Scuteri)

Arizona Cardinals wide receiver Marvin Harrison Jr., right, catches a touchdown pass as Seattle Seahawks cornerback Devon Witherspoon defends during the second half of an NFL football game Thursday, Sept. 25, 2025, in Glendale, Ariz. (AP Photo/Rick Scuteri)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.

Recommended Articles